|Poll|July 16, 2014

Poll: Is the Pelvic Exam Important?

New recommendations against routine pelvic exams in adult women with no symptoms have been issued by the American College of Physicians. What do you think?

The American College of Physicians (ACP) has recommended against routine pelvic exams in women aged 21 and older who are not pregnant and have no complaints about anything “down there.” The ACP bases this recommendation on too little evidence that these exams have meaningful clinical benefit. Some physicians have even stated that these exams have become more of a “rite” than “right.”

Will you follow the ACP’s new recommendation?

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Latest CME

Multimedia

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Poll: Is the Pelvic Exam Important?

Newsletter

Related Content

Cynthia Stuenkel, MD, talks evaluating and managing primary ovarian insufficiency

Danette Conklin, PhD, discusses cognitive behavioral therapy for menopausal symptom relief

Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

Early natural menopause linked to higher risk of metabolic syndrome

Latest CME

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Early estrogen use linked to lower disease risks

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

Clinical insights into vulvar health in menopause, with Melissa Mauskar, MD

Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD

Caroline Mitchell, MD, highlights safety and flexibility in treating GSM